NEWAMSTERDAM PHARMA COMPANY
NAMS·N62509109·US·Common Stock·Healthcare - Biotechnology-Activist
NAMS (NEWAMSTERDAM PHARMA COMPANY) is held by 94 institutional investors as of Q1 2026. Largest holders: Capital World Investors ($355.6M), RA CAPITAL MANAGEMENT, L.P. ($305.7M), FMR LLC ($280.6M). Net institutional sentiment: Mixed.
94
Holders
(8 Elite)
$2.4B
Total Value
55% (104)
Consensus
57 buying - 47 selling
13F: Insider & Congress:
Who's Trading
InsiderKFKooij Louise FrederikaSell $1.2MJun 22, 2026
InsiderKFKooij Louise FrederikaSell $9KJun 22, 2026
ActivistBIBCLS Fund III Investments, LP1.8%May 14, 2026
InsiderLGLANGE LOUIS GSell $1.3MMar 11, 2026
InsiderLGLANGE LOUIS GSell $14KMar 11, 2026
InsiderKPKastelein Johannes Jacob PieterSell $3.1MMar 9, 2026
InsiderLGLANGE LOUIS GSell $829KMar 6, 2026
InsiderKPKastelein Johannes Jacob PieterSell $2.9MMar 6, 2026
Showing 1-20 of 111
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer